• Home
  • /
  • Advanced Workshop on CAR-T Therapy: Oncology and Beyond
Find a workshopPay feeRequest a callbackVerify a certificate
Biotechnology · Advanced · Video-based learning

Advanced Workshop on CAR-T Therapy: Oncology and Beyond

Advancing CAR-T Therapy: From Oncology to Novel Applications

Access 24/7 · 365 daysVideo lectures of 3+ hrsCertificate
Registration open

About This Course

CAR-T therapy has revolutionized the field of oncology, offering personalized and highly effective treatments for certain cancers. This 3-day workshop dives deep into the biological principles behind CAR-T therapy, from T-cell engineering to antigen targeting, along with real-world applications and case studies in oncology. Participants will explore the full therapeutic landscape, including FDA-approved therapies and emerging treatments.
Beyond oncology, CAR-T therapy is now being explored for autoimmune diseases, infectious diseases, and other non-cancerous conditions. The workshop will discuss the future directions of CAR-T research and clinical trials, addressing the current hurdles in scaling these therapies. Participants will also engage in sessions, including CAR-T cell manufacturing, regulatory frameworks, and understanding the ethical considerations surrounding gene editing and cellular therapies.

Aim

This advanced workshop on “CAR-T Therapy: Oncology and Beyond” aims to provide a comprehensive understanding of Chimeric Antigen Receptor (CAR) T-cell therapy, its mechanisms, clinical applications, and future potential beyond oncology. Participants will gain insights into the latest developments, challenges, and innovations in CAR-T therapy for both cancer treatment and other emerging applications.

Course Objectives

  • Understand the fundamentals of CAR-T cell biology and immunotherapy mechanisms.
  • Explore CAR-T therapy applications in oncology and beyond.
  • Learn about the latest innovations, clinical trials, and emerging applications.
  • Gain knowledge of CAR-T cell manufacturing and regulatory requirements.
  • Discuss ethical, safety, and scalability challenges in CAR-T therapy.
Next: Syllabus →

Syllabus

Module 1: Introduction to CAR-T Therapy

Workshop Overview 

  • Introduction to the workshop structure and objectives
  • Importance of CAR-T therapy in modern oncology

Introduction to Immunotherapy 

  • What is immunotherapy?
  • The role of the immune system in cancer treatment
  • Overview of different immunotherapy approaches (Monoclonal antibodies, checkpoint inhibitors, CAR-T)

CAR-T Therapy Basics

  • What is CAR-T (Chimeric Antigen Receptor T-cell) therapy?
  • Mechanism of CAR-T: How it works (T-cell modification and cancer cell targeting)
  • Historical development of CAR-T therapy
  • Overview of FDA-approved CAR-T therapies (e.g., Kymriah, Yescarta, Breyanzi)

The Science Behind CAR-T 

  • T-cell biology and role in immune response
  • CAR-T cell structure and function: Antigen recognition, CAR components
  • Process of CAR-T cell therapy (from patient cell collection to infusion)

Clinical Indications of CAR-T Therapy

  • Types of cancers treated with CAR-T (leukemia, lymphoma, etc.)
  • Patient selection and eligibility criteria
  • Success rates and key clinical outcomes

Q&A and Recap

  • Open floor for questions
  • Summary of key learnings from Day 1

Module 2: CAR-T Therapy Manufacturing and Clinical Applications

Recap of Day 1 and Key Takeaways

  • Brief review of the fundamentals of CAR-T therapy

CAR-T Manufacturing Process

  • Overview of the CAR-T cell production process
  • Steps: T-cell collection, genetic modification (viral vectors), CAR-T expansion, and infusion
  • Challenges in manufacturing (scalability, cost, and logistics)
  • Ensuring safety and efficacy during production
  • Automation and emerging trends in CAR-T manufacturing

Clinical Administration of CAR-T Therapy

  • Patient preparation: Lymphodepleting chemotherapy
  • The CAR-T infusion process
  • Managing side effects and toxicities: Cytokine Release Syndrome (CRS), Neurotoxicity
  • CAR-T monitoring and patient management post-infusion
  • Long-term follow-up and remission rates

Real-World Case Studies

  • Analysis of real-world CAR-T patient outcomes (success stories and challenges)
  • Discussion of clinical trials and their significance in CAR-T advancements
  • Case study presentations with interactive Q&A

Q&A and Recap 

  • Address any questions
  • Summarize the session learnings

Module 3: Future Directions, Challenges, and Ethical Considerations

Recap of Day 2 and Key Takeaways

  • Brief review of the CAR-T manufacturing and clinical process

Advancements and Innovations in CAR-T

  • Next-generation CAR-T therapies: Dual-targeting CARs, armored CARs, and universal CAR-T cells
  • CAR-NK and other cellular therapies in development
  • Use of CAR-T beyond hematologic malignancies (solid tumors)
  • Emerging technology: CRISPR and gene editing in CAR-T optimization

Overcoming Current Challenges

  • Resistance to CAR-T therapy and relapse in patients
  • Addressing high costs and accessibility issues
  • Managing side effects more effectively
  • Overcoming the complexity of treating solid tumors

Ethical and Regulatory Considerations

  • Ethical challenges in gene-modified therapies (access, cost, and equity)
  • Informed consent and patient education
  • Regulatory pathways for CAR-T approval (FDA, EMA)
  • Impact of CAR-T on the healthcare system (insurance coverage, cost of care)

Future of CAR-T: Looking Ahead

  • Predictions for the next 5–10 years in CAR-T therapy
  • Personalized medicine and the integration of AI and data in CAR-T treatment
  • Potential for CAR-T in combination therapies

Open Discussion and Q&A

  • Group discussion on the future of CAR-T
  • Audience questions and expert responses

Conclusion and Wrap-Up 

  • Recap of the entire 3-day workshop
  • Final thoughts and takeaways

Who Should Enrol?

  • Undergraduate or graduate degree in Biotechnology, Immunology, Biomedical Sciences, or related fields.
  • Medical professionals, oncologists, and clinical researchers involved in cell-based therapies.
  • Individuals with an interest in gene therapy, cellular therapies, or advanced medical treatments.

Course Outcomes

  • Master CAR-T cell biology and engineering principles.
  • Gain insights into the clinical applications of CAR-T therapies in cancer and other diseases.
  • Understand the regulatory and ethical frameworks governing CAR-T therapies.
  • Acquire skills in CAR-T cell manufacturing and quality control.
  • Explore future innovations and applications of CAR-T beyond oncology.
Next: Fees →

Course fee

Learners in India

₹2,499

Learners outside India

$50

  • Video lectures
  • Study material
  • Certificate after completion
  • 365-day access

Enrol in the course

Next: FAQ →

Frequently asked questions

How is this course taught?

Through recorded video lectures from the original live workshop, with the study material. Watch at your own pace, any time.

How long do I have access?

365 days from your registration, on your NanoSchool dashboard.

Do I get a certificate?

Yes, an e-certificate after completion, with a QR code anyone can verify and an "Add to LinkedIn" button.

How can I pay?

By card, UPI or PayPal on the payment page; international bank transfer is also available there.

What is the refund policy?

See our Returns, Refunds & Cancellation policy: Returns, Refunds & Cancellation policy

Need Help?

We’re here for you!


(+91) 120-4781-217
WhatsApp +91 99581 61117

Registration open

More upcoming workshops

Live, mentor-led and certified. Dates and times in IST.

See all workshops
Support